The governing board of the $3 billion California stem cell agency is expected momentarily to discuss its plans for spending its remaining $800 million.
Key issues involve shifting funds away from basic research to research more oriented towards more directly producing therapies.
The meeting can be heard on the Internet by following the directions on the agenda.
No comments:
Post a Comment